2021 | 2020 | 2019 | 2018

Sep 18, 2020

Brii Biosciences Appoints Rogers Luo, Ankang Li To Leadership Positions

- Rogers Yongqing Luo, B.M., MBA, President of Brii Bio and General Manager for Greater China, will lead acceleration of Brii Bio’s China strategy and expand the company’s capabilities in access and partnerships
- Ankang Li, Ph.D., J.D., CFA, Brii Bio’s Chief Financial Officer, will lead all financial and corporate development functions


Mar 31, 2020

Tsinghua University, 3rd People’s Hospital of Shenzhen and Brii Biosciences Establish Partnership to Develop Neutralizing Antibodies Against COVID-19

-     Multiple highly potent, neutralizing antibodies already identified from convalesced patients
-     First-in-human trials planned for third quarter this year


Mar 11, 2020

Brii Biosciences Provides Funding to Columbia University for Research on COVID-19 and Other Coronaviruses

- Brii Biosciences will provide funding and expertise in infectious disease treatment modalities for projects in development in Aaron Diamond AIDS Research Center and other Columbia Laboratories